Peer-reviewedCC BY-NC-NDTranslational andrology and urology
An interpretable LASSO-Boruta nomogram for non-muscle-invasive bladder cancer recurrence after intravesical instillation
Related
- Urinary Extracellular Vesicle–Associated EphA2 Predicts Intravesical Recurrence in Bladder Cancer
- Sequential intravesical mitomycin-C and gemcitabine therapy for BCG-unresponsive high-risk non-muscle-invasive bladder cancer: protocol for a prospective, open-label, single-arm, multicentre phase II (IMGeS) study
- An interpretable machine-learning signature predicts early triple-negative breast cancer recurrence but adds no prognostic value beyond clinicopathological factors in external validation
- Clinicopathological predictors and an internally validated exploratory nomogram for 2-year recurrence after hepatic resection of hepatocellular carcinoma ≤5 cm.
- Risk factors for postoperative recurrence of chronic subdural hematoma and construction and validation of an online dynamic nomogram prediction model.
BibTeX
@article{anon2026interpretable,
title = {{An interpretable LASSO-Boruta nomogram for non-muscle-invasive bladder cancer recurrence after intravesical instillation}},
journal = {Translational andrology and urology},
year = {2026},
month = aug,
url = {https://europepmc.org/article/PMC/PMC13657710},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - An interpretable LASSO-Boruta nomogram for non-muscle-invasive bladder cancer recurrence after intravesical instillation
PY - 2026
DA - 2026/08/11
JO - Translational andrology and urology
UR - https://europepmc.org/article/PMC/PMC13657710
SN - 2223-4691
ER -